Pelcitoclax | m-entrepreneurship.com

Product Name :
Pelcitoclax

Search keywords :
Pelcitoclax

drugId :
null

Target Vo:
Apoptosis regulator Bcl-X

Target Vo Short Name :
Bcl-X

Moa_Name:
Apoptosis regulator Bcl-X inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Jiangsu Yasheng Pharmaceutical Development Co Ltd

Active Company_Name :
Ascentage Pharma Group Inc

Active Indication_Name:
Lymphoma, Non-Hodgkin

In Active Indication_Name:
Primary Myelofibrosis

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Minretumomab MedChemExpress
ATG4C Rabbit mAb Cancer
Phospho-RSK4 (Ser232) Antibody: Phospho-RSK4 (Ser232) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Phospho-RSK4 (Ser232). It can be used for WB,ICC/IF assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts